65000 ‘ghost patients’ underwent tests at mohalla clinics in Delhi last year, reveals ACB

Published On 2024-02-05 12:14 GMT   |   Update On 2024-02-05 12:14 GMT
Advertisement

An initial inquiry by the Anti-Corruption Branch (ACB) of the Delhi government has uncovered that 65,000 fictitious patients underwent pathological tests at Mohalla clinics through private labs from February to December 2023. Two private labs conducted around 2.2 million tests during this period, with 65,000 identified as fraudulent. The government paid ₹4.63 crore to these labs for the tests.

Last month, Delhi Lt Governor V K Saxena recommended a CBI probe into irregularities in lab tests at Mohalla clinics, leading to the Ministry of Home Affairs directing the CBI to investigate. The private labs allegedly conducted tests on non-existent patients who never visited any Mohalla Clinic, according to an ACB official.

For more news & updates, check out the link given below:

https://medicaldialogues.in/


Full View
Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News